Immune response to spiral ganglion neuron death in rats during development and after kanamycin-induced deafening

大鼠发育过程中及卡那霉素诱导耳聋后螺旋神经节神经元死亡的免疫反应

阅读:1

Abstract

Spiral ganglion neurons (SGNs) constitute the sole afferent connection between cochlear hair cells and central auditory nuclei. SGNs die during postnatal developmental pruning, and also following hair cell death, which can be triggered by ototoxic agents such as aminoglycoside antibiotics, including kanamycin. After hair cell loss, animal models show extensive SGN degeneration occurring gradually over a period of weeks to months. Here, we compared spatial and temporal patterns of SGN loss and immune cell involvement in these two cases of cell death in rats. Developmental SGN pruning occurred from postnatal day 5 (P5) to P8 in the basal half of the cochlea, and from P5 to P12 in the apical half. This was accompanied by a transient increase in spiral ganglion macrophages temporally and spatially correlated with SGN death, consistent with a role clearing degenerating neurons. After deafening neonatal rats with kanamycin injections, SGN death became evident at approximately 5.5 weeks of age and persisted throughout the ganglion, with greatest loss in the middle regions; less in the base and apex. Macrophage numbers also increased but neither temporally nor spatially correlated with SGN death. Rather, increased macrophage number and activation began approximately three weeks before SGN death and was highest in the apex. Additionally, T-cells and NK cells appeared in the ganglion concurrently with SGN degeneration. These observations suggest fundamentally different roles for macrophages post-deafening than during developmental pruning and, with prior observations that anti-inflammatory drugs reduce SGN death, support a causal role for immune responses in SGN death post-deafening.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。